Home » Topics » BioWorld Science

BioWorld Science
RSS

Servier discovers nuclear factor erythroid 2-related factor 2 activators

Sep. 27, 2021

Kallyope presents new free fatty acid FFA1 receptor agonists

Sep. 27, 2021

Japan Tobacco describes new PDHK2 inhibitors

Sep. 27, 2021

Perampanel ameliorates development of alpha-syn pathology in models of PD

Sep. 27, 2021

Researchers establish N. gonorrhoeae upper reproductive tract infection model

Sep. 27, 2021

SB-0107 shows antiparkinsonian activity in animal models

Sep. 27, 2021

LY-487379 shows synergistic effect on low-dose L-DOPA in a marmoset model

Sep. 27, 2021

Supera-CBD has superior potency over plant-derived CBD by factor of 8,000 times

Sep. 23, 2021

Mydecine reports preclinical data supporting MYCO-003 for anxiety and PTSD

Sep. 23, 2021

Lymph dysfunction identified as potential metabolic target

Sep. 23, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 6, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 6, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.